Caprolactam Quickview (CASRN 105-60-2)

Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.

Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.

For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.

Status of Data for Caprolactam

File First On-Line: 09/07/1988; Last Significant Revision: 09/01/1994

Category (section)	Status	Last Revised
Oral RfD Assessment	On-line	09/07/1988
Inhalation RfC Assessment	Message	09/01/1994
Carcinogenicity Assessment	No data

Synonyms

105-60-2
A1030
A1030N0
Akulon
Akulon M 2W

Alkamid
Amilan CM 1001
Amilan CM 1001C
Amilan CM 1001G
more...

Caprolactam Source Documents

Caprolactam Summary

Revision History

Date	Section	Description
04/01/1997	III., IV., V.	Drinking Water Health Advisories, EPA Regulatory Actions, and Supplementary Data were removed from IRIS on or before April 1997. IRIS users were directed to the appropriate EPA Program Offices for this information.

See IRIS Summary for complete revision history.

Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect	Point of Departure*	UF	MF	RfD
Reduced offspring body weight	NOAEL : 50 mg/kg-day	100	1	5 x10^-1 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

Principal and Supporting Studies (Oral RfD)
- Rat oral three generation reproduction study, Serotta et al., 1984
Confidence in the Oral RfD
- Study -- High
- Database -- High
- RfD -- High

Top of page

Reference Concentration for Chronic Inhalation Exposure (RfC)

Information reviewed but value not estimated. See IRIS Summary.

Top of page